Clinical Trial Update: Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating intra-erythrocyte dexamethasone sodium phosphate in patients with ataxia-telangiectasia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia-telangiectasia

Drugs mentioned

• Dexamethasone sodium phosphate (intra-erythrocyte formulation) (Dexamethasone sodium phosphate)

Snippet

Sponsor: Quince Therapeutics S.p.A. | Conditions: Nervous System Disorder, Genetic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2024-10-10